Board Meeting30 Oct 2026, 06:31 pm
Supriya Lifescience Board Meeting on Nov 6 to Approve Q2 FY27 Results
AI Summary
Supriya Lifescience Ltd has announced that its Board of Directors will convene on November 6, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company has closed its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the financial results are declared, in compliance with the Insider Trading Code.
Key Highlights
- Board meeting scheduled for November 6, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Trading window closed for designated persons.
- Compliance with SEBI LODR and Insider Trading Code.
Price Impact
More from SUPRIYA